Haemophilia

Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal
pp. 451-461(11)
Authors: SUMNER, M. J.; GELDZILER, B. D.; PEDERSEN, M.; SEREMETIS, S.

A cost evaluation of treatment alternatives for mild-to-moderate bleeding episodes in patients with haemophilia and inhibitors in Brazil
pp. 462-469(8)
Authors: OZELO, M. C; VILLAÇA, P. R; DE ALMEIDA, J. O. S. C; BUENO, T. M. F; DE MIRANDA, P. A. P; HART, W. M; KARAMALIS, M

Reconstituting factor concentrates: Defining Evidence of Coaching Non-Experts (DEVICE) in haemophilia - a prospective randomized feasibility study
pp. 470-472(3)
Authors: BIDLINGMAIER, C.; KURNIK, K.; HÖLSCHER, G.; KAPPLER, M.

Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data
pp. 473-479(7)
Authors: RICHARDS, M.; ALTISENT, C.; BATOROVA, A.; CHAMBOST, H.; DOLAN, G.; DE MOERLOOSE, P.; FRAGA, M.; HERMANS, C.; KARAFOULIDOU, A.; KLAMROTH, R.; LASSILA, R.; ROTHSCHILD, C.

A haemophilia treatment centre-administered disease management programme in patients with bleeding disorders
pp. 480-488(9)
Authors: TENCER, T.; ROBERSON, C.; DUNCAN, N.; JOHNSON, K.; SHAPIRO, A.

Haematuria in patients with haemophilia and its influence on renal function and proteinuria
pp. 489-492(4)
Authors: BENEDIK-DOLNIČAR, M.; BENEDIK, M.

Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population
pp. 493-501(9)
Authors: DU TREIL, S.; RICE, J.; LEISSINGER, C. A.

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres
pp. 502-507(6)
Authors: MORFINI, M.; AUERSWALD, G.; KOBELT, R. A.; RIVOLTA, G. F.; RODRIGUEZ-MARTORELL, J.; SCARAGGI, F. A.; ALTISENT, C.; BLATNY, J.; BOREL-DERLON, A.; ROSSI, V.

Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review
pp. 508-517(10)
Authors: KRAUT, E. H.; ALEDORT, L. M.; ARKIN, S.; STINE, K. C.; WONG, W.-Y.

Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia
pp. 518-526(9)
Authors: WEBERT, K. E.; ARNOLD, D. M.; CARRUTHERS, J.; MOLNAR, L.; ALMONTE, T.; DECKER, K.; SEROSKI, W.; REED, J.; CHAN, A. K.; PAI, M.; WALKER, I. R.

A randomized, double-blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25°C stable formulation
pp. 527-532(6)
Authors: BYSTED, B. V.; SCHARLING, B.; MØLLER, T.; HANSEN, B. L.

Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients
pp. 533-541(9)
Authors: BROPHY, D. F.; MARTIN, E. J.; NOLTE, M. E.; KUHN, J. G.; CARR JR, M. E.

Can early subclinical gait changes in children with haemophilia be identified using the GAITRite^® walkway
pp. 542-547(6)
Authors: BLADEN, M.; ALDERSON, L.; KHAIR, K.; LIESNER, R.; GREEN, J.; MAIN, E.

Intranasal desmopressin (Octim^TM): a safe and efficacious treatment option for children with bleeding disorders
pp. 548-551(4)
Authors: KHAIR, K.; BAKER, K.; MATHIAS, M.; BURGESS, C.; LIESNER, R.

Intracranial bleeding in haemophilia beyond the neonatal period - the role of CT imaging in suspected intracranial bleeding
pp. 552-559(8)
Authors: TRAIVAREE, C.; BLANCHETTE, V.; ARMSTRONG, D.; FLOROS, G.; STAIN, A. M.; CARCAO, M. D.

Utility of computed tomography of the head following head trauma in boys with haemophilia
pp. 560-566(7)
Authors: WITMER, C. M.; RAFFINI, L. J.; MANNO, C. S.

Incidence of factor FVIIIC deficiency in live male infants undergoing circumcision in South West, Nigeria
pp. 567-569(3)
Authors: FAKUNLE, E. E.; SHOKUNBI, W. A.; SHITTU, O. B.

Parents of children with haemophilia - a transforming experience
pp. 570-579(10)
Authors: BEETON, K.; NEAL, D.; WATSON, T.; LEE, C. A.

Transmissible spongiform encephalopathy agent clearance by the immunoaffinity and anion-exchange chromatography steps of the ReFacto^® manufacturing process
pp. 580-587(8)
Authors: BOOTH, J.; VICIK, S.; TANNATT, M.; GALLO, C.; KELLEY, B.

Feasibility, safety and cost-effectiveness of transjugular liver biopsy following major surgery in patients with haemophilia
pp. 588-592(5)
Authors: DETRAIT, M.; POTHEN, D.; BRENARD, R.; STARKEL, P.; HERMANS, C.

Haematological support during peg-interferon therapy for HCV-infected haemophiliacs improves virological outcomes
pp. 593-598(6)
Authors: KEVANS, D.; FARRELL, G.; HOPKINS, S.; MAHMUD, N.; WHITE, B.; NORRIS, S.; BERGIN, C.

An outline of the current orthopaedic management of haemophilic disease of the upper limb
pp. 599-605(7)
Authors: CHOUDHURY, M. Z. B.; MANN, H. A.; GODDARD, N. J.; LEE, C. A.

European Study on Orthopaedic Status of haemophilia patients with inhibitors
pp. 606-612(7)
Authors: MORFINI, M.; HAYA, S.; TAGARIELLO, G.; POLLMANN, H.; QUINTANA, M.; SIEGMUND, B.; STIELTJES, N.; DOLAN, G.; TUSELL, J.

Orthopaedic surgery for inhibitor patients: a series of 27 procedures (25 patients)
pp. 613-619(7)
Authors: RODRIGUEZ-MERCHAN, E. C.; QUINTANA, M.; JIMENEZ-YUSTE, V.; HERNÁNDEZ-NAVARRO, F.

Psychometric analysis of the Functional Independence Score in Haemophilia (FISH)
pp. 620-626(7)
Authors: POONNOOSE, P. M.; THOMAS, R.; KESHAVA, S. N.; CHERIAN, R. S.; PADANKATTI, S.; PAZANI, D.; KAVITHA, M. L.; DEVADARASINI, M.; BHATTACHARJI, S.; VISWABANDYA, A.; JOHN, J. A.; MACADEN, A. S.; MATHEWS, V.; SRIVASTAVA, A.

The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre
pp. 627-632(6)
Authors: MIKHAIL, S.; VARADARAJAN, R.; KOUIDES, P.

Attitudes towards and beliefs about genetic testing in the haemophilia community: a qualitative study
pp. 633-641(9)
Authors: THOMAS, S.; HERBERT, D.; STREET, A.; BARNES, C.; BOAL, J.; KOMESAROFF, P.

New FACTOR IX linked marker alleles in African Haemophilia B patients
pp. 642-644(3)
Authors: MITCHELL, C.; MITCHELL, C. L.; KRAUSE, A.

Compound heterozygosity for two novel mutations (1203insG/Y1456X) in the von Willebrand factor gene causing type 3 von Willebrand disease
pp. 645-648(4)
Authors: XIE, F.; WANG, X.; COOPER, D. N.; LAN, F.; FANG, Y.; CAI, X.; WANG, Z.; WANG, H.

Phenotype - genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations
pp. 649-657(9)
Authors: IVASKEVICIUS, V.; WINDYGA, J.; BARAN, B.; SCHROEDER, V.; JUNEN, J.; BYKOWSKA, K.; SEIFRIED, E.; KOHLER, H. P.; OLDENBURG, J.

Meeting Report: Ninth and Tenth Workshops of the European Paediatric Network for Haemophilia Management (PedNet)
pp. 658-662(5)
Authors: KURNIK, K.; THOMAS, A. E.

Safety of human plasma-derived clotting factor products and their role in haemostasis in patients with haemophilia: meeting report
pp. 663-669(7)
Authors: TARANTINO, M.; MA, A.; ALEDORT, L.

Oesophago-gastrectomy in a patient with haemophilia A
pp. 670-671(2)
Authors: NANAYAKKARA, P. R.; SAMARASEKERA, D. N.; GAMAGE, H. N. S.; ABAYADEERA, A. U.; DE SILVA, H. J.

The `leaking' of the perirenal haematoma into peritoneum mimicking acute abdomen in a patient with von Willebrand's Disease following blunt abdominal trauma
pp. 672-674(3)
Authors: YILMAZ, S.; ACAR, M.; BUKULMEZ, A.; YAZICIOGLU, B.; YAPRAK, O.; SEN, T.; GURSEL, T.

Acquired von Willebrand's syndrome in a patient with severe primary hypothyroidism associated with myasthenia gravis in the course of autoimmune polyglandular syndrome type 3
pp. 675-676(2)
Authors: LUBINSKA, M.; SWIATKOWSKA-STODULSKA, R.; KAZIMIERSKA, E.; SWORCZAK, K.

Coagulation monitoring with thrombin generation test during endoscopic extraperitoneal radical prostatectomy for prostate cancer in a patient with severe haemophilia B
pp. 677-679(3)
Authors: PETROS, S.; SIEGEMUND, T.; STOLZENBURG, J.-U.; SIEGEMUND, A.; ENGELMANN, L.

Methodological shortcomings in assessment of factor VIII concentrate inhibition
pp. 680-681(2)
Authors: VERBRUGGEN, B.; VAN HEERDE, W.; BUDDE, U.

Characterization of sequence breakpoints in two haemophiliac patients with large FVIII gene deletions
pp. 682-684(3)
Authors: FERNÁNDEZ-LÓPEZ, O.; GARCÍA-LOZANO, J. R.; NÚÑEZ-VÁZQUEZ, R.; PÉREZ-GARRIDO, R.; NÚÑEZ-ROLDÁN, A.